Pardon Our Appearance as we become Curative Biotechnology, Inc.* We Focus on Identifying, In Licensing and Developing Disease Modifying Therapeutic Drug Candidates with a Concentration on Rare Disease Indications

Our unique business model coupled with deep industry leadership experience enables us to build a pipeline of first in class drugs with accelerated development pathways to address the unmet medical needs of patients.

Want Further Updates? Join Our Mailing List: